These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diastereomerically pure nucleoside-5'-O-(2-thio-4,4-pentamethylene-1,3,2-oxathiaphospholane)s--substrates for synthesis of P-chiral derivatives of nucleoside-5'-O-phosphorothioates. Tomaszewska A; Guga P; Stec WJ Chirality; 2011 Mar; 23(3):237-44. PubMed ID: 20928893 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of fully protected trinucleotide building blocks on a disulphide-linked soluble support. Suchsland R; Appel B; Virta P; Müller S RSC Adv; 2021 Jan; 11(7):3892-3896. PubMed ID: 35424330 [TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide Therapeutics: From Discovery and Development to Patentability. Moumné L; Marie AC; Crouvezier N Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213992 [TBL] [Abstract][Full Text] [Related]
9. Development of Kilogram-Scale Convergent Liquid-Phase Synthesis of Oligonucleotides. Zhou X; Kiesman WF; Yan W; Jiang H; Antia FD; Yang J; Fillon YA; Xiao L; Shi X J Org Chem; 2022 Feb; 87(4):2087-2110. PubMed ID: 34807599 [TBL] [Abstract][Full Text] [Related]
10. More versatile synthesis of oligonucleotides. Virta P Science; 2021 Sep; 373(6560):1196-1197. PubMed ID: 34516804 [TBL] [Abstract][Full Text] [Related]